mice treated intravenously with either mab ma1-6 ( anti-h2 ) or ma2-10 ( anti-f ) , or a combination of these two mabs and mab ma4-4 ( anti-f ) , two hours before corneal challenge with the viable bacteria , exhibited significantly less corneal disease than mice either not treated with the mabs , treated with ma4-4 alone or treated with mab ma1-3 ( anti-i ) .
C0010031
corneal
C0010034
corneal disease